TBPH stock pitch - 2024-07-09

Added to YB: 2024-07-09

Pitch date: 2024-07-09

Theravance Biopharma, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States.

Market Cap

$687.6M

Pitch Price

$8.97

Price Target

N/A

Dividend

N/A

EV/EBITDA

-12.82

P/E

23.38

EV/Sales

4.97

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.